scholarly journals Correction to: Importance of evaluating protein glycosylation in pluripotent stem cell‑derived cardiomyocytes for research and clinical applications

Author(s):  
Maia I. Kelly ◽  
Mustafa Albahrani ◽  
Chase Castro ◽  
Ellen Poon ◽  
Bin Yan ◽  
...  
Hepatology ◽  
2021 ◽  
Author(s):  
Eléanor Luce ◽  
Antonietta Messina ◽  
Jean‐Charles Duclos‐Vallée ◽  
Anne Dubart‐Kupperschmitt

2013 ◽  
pp. 57-76
Author(s):  
James E. Hudson ◽  
Peter Christalla ◽  
Wolfram-Hubertus Zimmermann

2016 ◽  
Vol 4 (20) ◽  
pp. 3433-3442 ◽  
Author(s):  
B. Lucendo-Villarin ◽  
H. Rashidi ◽  
K. Cameron ◽  
D. C. Hay

Pluripotent stem cell derived liver cells (hepatocytes) represent a promising alternative to primary tissue for biological and clinical applications.


2018 ◽  
Vol 22 (4) ◽  
pp. 485-499 ◽  
Author(s):  
Loukia Yiangou ◽  
Alexander D.B. Ross ◽  
Kim Jee Goh ◽  
Ludovic Vallier

Cells ◽  
2018 ◽  
Vol 7 (6) ◽  
pp. 48 ◽  
Author(s):  
Angela Di Baldassarre ◽  
Elisa Cimetta ◽  
Sveva Bollini ◽  
Giulia Gaggi ◽  
Barbara Ghinassi

2017 ◽  
Vol 37 (11) ◽  
pp. 2007-2013 ◽  
Author(s):  
Sara Borst ◽  
Xiuli Sim ◽  
Mortimer Poncz ◽  
Deborah L. French ◽  
Paul Gadue

Platelets, derived from megakaryocytes, are anucleate cytoplasmic discs that circulate in the blood stream and play major roles in hemostasis, inflammation, and vascular biology. Platelet transfusions are used in a variety of medical settings to prevent life-threatening thrombocytopenia because of cancer therapy, other causes of acquired or inherited thrombocytopenia, and trauma. Currently, platelets used for transfusion purposes are donor derived. However, there is a drive to generate nondonor sources of platelets to help supplement donor-derived platelets. Efforts have been made by many laboratories to generate in vitro platelets and optimize their production and quality. In vitro-derived platelets have the potential to be a safer, more uniform product, and genetic manipulation could allow for better treatment of patients who become refractory to donor-derived units. This review focuses on potential clinical applications of in vitro-derived megakaryocytes and platelets, current methods to generate and expand megakaryocytes from pluripotent stem cell sources, and the use of these cells for disease modeling.


2015 ◽  
Vol 4 (3) ◽  
pp. 217-223 ◽  
Author(s):  
Anna French ◽  
Christopher Bravery ◽  
James Smith ◽  
Amit Chandra ◽  
Peter Archibald ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document